Entity type
Company
Filer Snapshot
Aridis Pharmaceuticals, Inc.
CIK 0001614067. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
313
Latest filing
15 May 2026
Industry
Pharmaceutical Preparations
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
—
No parsed Forms 3/4/5 owner position for this CIK.
Browse insider filingsSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Schedule 13D/G
View Source Filing
SCHEDULE 13G/A filed on 15 May 2026 for CIK 0001614067.
- Business address
- 983 University Avenue, Bldg. B, Los Gatos, CA, 95032
- State of incorporation
- DE
- Fiscal year end
- 31 December
Identity
SEC record
Filer intelligence
What SEC filings say about Aridis Pharmaceuticals, Inc.
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
13F portfolio
No rows yet
Quarterly institutional portfolio holdings.
13D/G stakes
No rows yet
Beneficial ownership and large-stake disclosures.
Forms 3/4/5
No rows yet
Officer, director, and 10% owner holdings or transactions.
No parsed ownership summary yet
We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.
Latest update
What changed recently for Aridis Pharmaceuticals, Inc.
Latest financial period: Q3 2023. Open the source-backed page to inspect the fresh filing or facts context.
Update date
06 Nov 2023
Page type
Company facts
Latest period
Q3 2023
SEC-backed company facts were refreshed from filings filed on 06 Nov 2023.
Benchmark Context
Benchmark context for this company
Aridis Pharmaceuticals, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q3 2023. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 06 Nov 2023.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0001614067 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
313
First seen
17 Jul 2014
Latest filing
15 May 2026
Entity
Company
Observed form types
SCHEDULE 13G/A
SC 13G/A
4
8-K
DEFA14A
10-Q
ARS
DEF 14A
25-NSE
424B5
+27 more
Industry context: Pharmaceutical Preparations.
Latest Filings
Showing the latest 12 of 313 SEC filings for Aridis Pharmaceuticals, Inc..
SCHEDULE 13G/A
File 005-92440
SCHEDULE 13G/A filing
- Filing date
- 15 May 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SCHEDULE 13G/A
File 005-92440
SCHEDULE 13G/A filing
- Filing date
- 17 Feb 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SCHEDULE 13G/A
File 005-92440
SCHEDULE 13G/A filing
- Filing date
- 14 Aug 2025
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SCHEDULE 13G/A
File 005-92440
SCHEDULE 13G/A filing
- Filing date
- 15 May 2025
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SCHEDULE 13G/A
File 005-92440
SCHEDULE 13G/A filing
- Filing date
- 14 Feb 2025
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-92440
SC 13G/A filing
- Filing date
- 14 Nov 2024
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 28 Jun 2024
- Reporting date
- 27 Jun 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 28 Jun 2024
- Reporting date
- 27 Jun 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 28 Jun 2024
- Reporting date
- 27 Jun 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 28 Jun 2024
- Reporting date
- 24 Jun 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 28 Jun 2024
- Reporting date
- 24 Jun 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-38630
8-K filing
- Filing date
- 27 Jun 2024
- Reporting date
- 24 Jun 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing